DOCSLIB.ORG

Induction of Diabetes in the RIP-B7.1 Mouse Model Is Critically Dependent on TLR3 and Myd88 Pathways and Is Associated with Alte

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Induction of Diabetes in the RIP-B7.1 Mouse Model Is Critically Dependent on TLR3 and Myd88 Pathways and Is Associated with Alte Diabetes Volume 63, February 2014 619 Aimon K. Alkanani,1 Naoko Hara,1 Egil Lien,2 Diana Ir,3 Cassandra V. Kotter,3 Charles E. Robertson,4,5 Brandie D. Wagner,5,6 Daniel N. Frank,3,5 and Danny Zipris1 Induction of Diabetes in the RIP-B7.1 Mouse Model Is Critically Dependent on TLR3 and MyD88 Pathways and Is Associated With Alterations IMMUNOLOGY AND TRANSPLANTATION in the Intestinal Microbiome RIP-B7.1 transgenic mice express B7.1 TLR9-deficient mice treated with antibiotics plus costimulatory molecules in pancreatic islets and poly I:C had higher bacterial diversity compared with develop diabetes after treatment with polyinosinic: disease-resistant mice. Furthermore, principal polycytidylic acid (poly I:C), a synthetic double- component analysis suggested that TLR9-deficient stranded RNA and agonist of Toll-like receptor (TLR) 3 mice had distinct gut microbiome compared with the and retinoic acid–inducible protein I. We used this diabetes-resistant mice. Finally, the administration model to investigate the role of TLR pathways and of sulfatrim plus poly I:C to TLR9-deficient mice intestinal microbiota in disease progression. RIP- resulted in alterations in the abundance of gut B7.1 mice homozygous for targeted disruption of bacterial communities at the phylum and genus TLR9, TLR3, and myeloid differentiation factor-88 levels. These data imply that the induction of (MyD88), and most of the wild-type RIP-B7.1 mice diabetes in the RIP-B7.1 model is critically housed under normal conditions remained diabetes- dependent on TLR3 and MyD88 pathways, and free after poly I:C administration. However, the involves modulation of the intestinal microbiota. majority of TLR9-deficient mice and wild-type Diabetes 2014;63:619–631 | DOI: 10.2337/db13-1007 animals treated with poly I:C and an antibiotic developed disease. In sharp contrast, TLR3- and MyD88-deficient mice were protected from diabetes Type 1 diabetes (T1D) is a proinflammatory autoimmune following the same treatment regimen. High- disease that involves the specific destruction of pancre- throughput DNA sequencing demonstrated that atic b-cells (1). The etiology of the disease is incompletely 1Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, 6Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO University of Colorado Denver, Aurora, CO 2Department of Medicine, Division of Infectious Diseases and Immunology, Corresponding author: Danny Zipris, [email protected]. University of Massachusetts Medical School, Worcester, MA Received 27 June 2013 and accepted 7 October 2013. 3Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO This article contains Supplementary Data online at http://diabetes 4Department of Molecular, Cellular, and Developmental Biology, University of .diabetesjournals.org/lookup/suppl/doi:10.2337/db13-1007/-/DC1. Colorado, Boulder, CO © 2014 by the American Diabetes Association. See http://creativecommons 5University of Colorado Microbiome Research Consortium, Aurora, CO .org/licenses/by-nc-nd/3.0/ for details. 620 TLR Pathways in the RIP-B7.1 Mouse Diabetes Volume 63, February 2014 understood; however, epidemiological data and evidence The B7.1 transgene expression and/or gene mutation from animal models of T1D implicate microbes in the were detected by PCR amplification using genomic DNA disease course (2). isolated from tail snips (22). All animals were housed in The innate immune system uses pattern-recognition a specific pathogen-free facility and maintained in ac- receptors, such as Toll-like receptors (TLRs), nucleotide- cordance with the Guide for the Care and Use of Labo- binding oligomerization domain (NOD)-like receptors, ratory Animals (published by the National Institutes of and retinoic acid–inducible gene-1 (RIG-I)–like receptors, Health, NIH publication no. 86-23, revised 1996) and the to detect and eradicate microbial infections (3). Inter- guidelines of the Institutional Animal Care and Use actions between TLRs and their ligands initiate a series of Committee of the University of Colorado Denver. intracellular signaling events leading to the expression of fl TLR Activation, Antibiotic Treatment, Blood Removal, antimicrobial genes, proin ammatory cytokines, and and Serum p40 Measurements chemokines, such as type I interferons, interleukin (IL)-1, To induce diabetes, mice at 6–8 weeks of age were IL-6, IL-12, and chemokine (C-X-C motif) ligand-10 (3,4). injected intraperitoneally with 5 mg/g body weight poly I: Emerging evidence has implicated the innate immune C (Sigma-Aldrich, St. Louis, MO) on 10 consecutive days. system and TLR pathways in the mechanism of T1D Mice were given normal water or water supplemented (reviewed in Chervonsky [5], Wong and Wen [6], and with sulfatrim (1 mg/mL sulfamethoxazole plus 0.2 Zipris [7]). mg/mL trimethoprim; Hi-Tech Pharmacal, Amityville, The gut microbiota play a central role in shaping the NY) beginning at birth and continuing for the duration of peripheral and intestinal immune systems in health and the experiment. Animals were monitored for disease disease (5,8–10). The gut microbiome has recently been development for at least 200 days after poly I:C treat- implicated in chronic proinflammatory disorders, in- ment. Blood glucose was measured twice a week, and the cluding T1D (11–18). A temporal decline in members of mice were considered diabetic after two consecutive the bacterial phyla Firmicutes and an increase in Bac- blood glucose test results of .250 mg/dL. To investigate teroidetes has been observed in individuals that are at the expression of the p40 subunit of IL-12 and IL-23, risk for developing T1D, compared with healthy subjects mice received 5 mg/g body weight of poly I:C or CpG DNA (13). Other investigators have shown that intestinal (TriLink BioTechnologies). Blood was collected 6 h after bacteria are associated with T1D in the diabetes-prone the treatment. Sera were separated from blood cells im- BioBreeding rat (19), the LEW1.WR1 rat model of virus- mediately after blood collection and stored at 280°C induced T1D (20), and the NOD mouse (14,21). until use. The serum level of the p40 subunit of IL-12 The RIP-B7.1 transgenic mouse expresses B7.1 co- and IL-23 was measured using a commercial kit from Life stimulatory molecules under the control of the rat insulin Technologies-Invitrogen (Carlsbad, CA) according to the promoter (22). The administration of double-stranded manufacturer’s instructions. RNA, a ligand of TLR3 and RIG-like helicases, in these animals results in diabetes via mechanisms that have DNA Isolation and Quantitative RT-PCR Analysis for been hypothesized to involve type I interferon pathways the Detection of Gut Bacteria (23) and the upregulation of antigen-presenting cells The Lactobacillus, Bifidobacterium, Clostridium, and Bac- and T-cell auto-reactivity (24). In the current study, we teroides genera were detected in stool DNA by quantita- used the RIP-B7.1 mouse model of diabetes to investigate tive PCR analysis using previously published primers the role of TLR pathways and the intestinal microbiota in (26). Bacterial DNA was recovered from stool using the the mechanism of disease induction. We demonstrate QIAmp DNA stool mini kit (Qiagen, Valencia, CA) that the TLR3 and myeloid differentiation factor-88 according to the manufacturer’s instructions. DNA con- (MyD88) pathways, but not the TLR9 pathway, play centrations were determined using a NanoDrop ND-1000 a critical role in the mechanism of islet destruction. spectrophotometer (Thermo Scientific, Wilmington, DE). Furthermore, we provide evidence that alterations in the The data were normalized to the total bacterial DNA in gut microbiota may be involved in the course of poly- each sample using previously described primers and inosinic:polycytidylic acid (poly I:C)–induced diabetes in conditions (26). this animal model. High-Throughput DNA Sequencing for Microbiome RESEARCH DESIGN AND METHODS Analysis Mice 16S Amplicon Library Construction C57BL/6 mice with pancreatic b-cells expressing B7.1 Bacterial profiles from the mice were determined by costimulatory molecules under the rat insulin promoter broad-range amplification and sequence analysis of 16S (RIP-B7.1) were produced as previously described (22) ribosomal RNA (rRNA) genes following our previously and bred in the University of Colorado animal facility. To described methods (20,27). In brief, amplicons were generate RIP-B7.1 mice deficient in TLR9, TLR3, or generated using primers that target approximately 300 MyD88, RIP-B7.1 mice were bred to homozygosity with base pairs of the V4 variable region of the 16S rRNA C57BL/6 mice deficient in TLR9, TLR3, or MyD88 (25). gene. PCR products were normalized using a SequalPrep diabetes.diabetesjournals.org Alkanani and Associates 621 kit (Invitrogen), and were pooled, lyophilized, purified, component analysis (PCA) was performed using singular and concentrated using a DNA Clean and Concentrator value decomposition of the centered data using the Kit (Zymo, Irvine, CA). Pooled amplicons was quantified prcomp function in R. A small constant (1/total number using Qubit Fluorometer 2.0 (Invitrogen). The pool was of sequences) was added to the counts prior to the ap- diluted to 2 nmol/L and denatured with 0.2N NaOH at plication of the centered log ratio transformation rec- room temperature. The denatured DNA was diluted to 15 ommended for compositional data (35,36). pmol/L and spiked with 25% of the Illumina PhiX control DNA prior to loading the sequencer. Illumina paired-end RESULTS sequencing was performed on the Miseq platform with Poly I:C–Induced Diabetes in RIP-B7.1 Mice with version 2.0 of the Miseq Control Software, using a 500- Disrupted TLR Signaling cycle version 2 reagent kit. TLR pathways have been suggested to play a key role in the mechanism leading to diabetes in humans and in an Analysis of Illumina Paired-End Reads animal model (5,6,37,38).
Load more

Recommended publications
  • Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis
    International Journal of Molecular Sciences Review Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis David Johane Machate 1, Priscila Silva Figueiredo 2 , Gabriela Marcelino 2 , Rita de Cássia Avellaneda Guimarães 2,*, Priscila Aiko Hiane 2 , Danielle Bogo 2, Verônica Assalin Zorgetto Pinheiro 2, Lincoln Carlos Silva de Oliveira 3 and Arnildo Pott 1 1 Graduate Program in Biotechnology and Biodiversity in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; [email protected] (D.J.M.); [email protected] (A.P.) 2 Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; pri.fi[email protected] (P.S.F.); [email protected] (G.M.); [email protected] (P.A.H.); [email protected] (D.B.); [email protected] (V.A.Z.P.) 3 Chemistry Institute, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; [email protected] * Correspondence: [email protected]; Tel.: +55-67-3345-7416 Received: 9 March 2020; Accepted: 27 March 2020; Published: 8 June 2020 Abstract: Long-term high-fat dietary intake plays a crucial role in the composition of gut microbiota in animal models and human subjects, which affect directly short-chain fatty acid (SCFA) production and host health. This review aims to highlight the interplay of fatty acid (FA) intake and gut microbiota composition and its interaction with hosts in health promotion and obesity prevention and its related metabolic dysbiosis.
    [Show full text]
  • WO 2018/064165 A2 (.Pdf)
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/064165 A2 05 April 2018 (05.04.2018) W !P O PCT (51) International Patent Classification: Published: A61K 35/74 (20 15.0 1) C12N 1/21 (2006 .01) — without international search report and to be republished (21) International Application Number: upon receipt of that report (Rule 48.2(g)) PCT/US2017/053717 — with sequence listing part of description (Rule 5.2(a)) (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/400,372 27 September 2016 (27.09.2016) US 62/508,885 19 May 2017 (19.05.2017) US 62/557,566 12 September 2017 (12.09.2017) US (71) Applicant: BOARD OF REGENTS, THE UNIVERSI¬ TY OF TEXAS SYSTEM [US/US]; 210 West 7th St., Austin, TX 78701 (US). (72) Inventors: WARGO, Jennifer; 1814 Bissonnet St., Hous ton, TX 77005 (US). GOPALAKRISHNAN, Vanch- eswaran; 7900 Cambridge, Apt. 10-lb, Houston, TX 77054 (US). (74) Agent: BYRD, Marshall, P.; Parker Highlander PLLC, 1120 S. Capital Of Texas Highway, Bldg. One, Suite 200, Austin, TX 78746 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Gut Commensal Microbiota and Intestinal Inflammation: Modulatory Role of Rifaximin
    ADVERTIMENT. Lʼaccés als continguts dʼaquesta tesi queda condicionat a lʼacceptació de les condicions dʼús establertes per la següent llicència Creative Commons: http://cat.creativecommons.org/?page_id=184 ADVERTENCIA. El acceso a los contenidos de esta tesis queda condicionado a la aceptación de las condiciones de uso establecidas por la siguiente licencia Creative Commons: http://es.creativecommons.org/blog/licencias/ WARNING. The access to the contents of this doctoral thesis it is limited to the acceptance of the use conditions set by the following Creative Commons license: https://creativecommons.org/licenses/?lang=en Gut Commensal Microbiota and Intestinal Inflammation: Modulatory Role of Rifaximin by Marina Ferrer Clotas A dissertation in partial fulfilment of the requirements for the degree of Doctor of Philosophy Neuroscience Doctoral Programme Department of Cell Biology, Physiology and Immunology Neuroscience Institute Universitat Autònoma de Barcelona Ph.D. Advisor Dr. Vicente Martínez Perea Faculty of Veterinary Medicine Bellaterra (Barcelona), November 2019 Vicente Martínez Perea, Associate Professor of Physiology at the Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona; I hereby declare that the Thesis entitled “Gut Commensal Microbiota and Intestinal Inflammation: Modulatory Role of Rifaximin”, submitted by MARINA FERRER CLOTAS in partial fulfillment of the requirements for the degree of Doctor of Philosophy, has been carried out under my supervision and I authorize the submission to
    [Show full text]
  • CGM-18-001 Perseus Report Update Bacterial Taxonomy Final Errata
    report Update of the bacterial taxonomy in the classification lists of COGEM July 2018 COGEM Report CGM 2018-04 Patrick L.J. RÜDELSHEIM & Pascale VAN ROOIJ PERSEUS BVBA Ordering information COGEM report No CGM 2018-04 E-mail: [email protected] Phone: +31-30-274 2777 Postal address: Netherlands Commission on Genetic Modification (COGEM), P.O. Box 578, 3720 AN Bilthoven, The Netherlands Internet Download as pdf-file: http://www.cogem.net → publications → research reports When ordering this report (free of charge), please mention title and number. Advisory Committee The authors gratefully acknowledge the members of the Advisory Committee for the valuable discussions and patience. Chair: Prof. dr. J.P.M. van Putten (Chair of the Medical Veterinary subcommittee of COGEM, Utrecht University) Members: Prof. dr. J.E. Degener (Member of the Medical Veterinary subcommittee of COGEM, University Medical Centre Groningen) Prof. dr. ir. J.D. van Elsas (Member of the Agriculture subcommittee of COGEM, University of Groningen) Dr. Lisette van der Knaap (COGEM-secretariat) Astrid Schulting (COGEM-secretariat) Disclaimer This report was commissioned by COGEM. The contents of this publication are the sole responsibility of the authors and may in no way be taken to represent the views of COGEM. Dit rapport is samengesteld in opdracht van de COGEM. De meningen die in het rapport worden weergegeven, zijn die van de auteurs en weerspiegelen niet noodzakelijkerwijs de mening van de COGEM. 2 | 24 Foreword COGEM advises the Dutch government on classifications of bacteria, and publishes listings of pathogenic and non-pathogenic bacteria that are updated regularly. These lists of bacteria originate from 2011, when COGEM petitioned a research project to evaluate the classifications of bacteria in the former GMO regulation and to supplement this list with bacteria that have been classified by other governmental organizations.
    [Show full text]
  • Individual Differences in Members of Actinobacteria, Bacteroidetes, and Firmicutes Is
    bioRxiv preprint doi: https://doi.org/10.1101/2021.07.23.453592; this version posted July 24, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Individual differences in members of Actinobacteria, Bacteroidetes, and Firmicutes is associated with resistance or vulnerability to addiction-like behaviors in heterogeneous stock rats 1 1 1 1 1 1 1 S. Simpson , G. de Guglielmo , M. Brennan , L. Maturin , G. Peters , H. Jia , E. Wellmeyer , S. Andrews1, L. Solberg Woods2, A. A. Palmer1,3, O. George1* 1Department of Psychiatry, University of California San Diego, La Jolla CA 92093, USA 2Department of Internal MediCine, SeCtion on MoleCular MediCine, Wake Forest University SChool of MediCine, Winston-Salem, NC 27157 3 Institute for GenomiC MediCine, University of California, San Diego, La Jolla, CA 92093 *Corresponding Author Dr. Olivier George, Department of Psychiatry University of California San Diego La Jolla, CA 92093, USA. Tel: +18582465538. E-mail:[email protected] bioRxiv preprint doi: https://doi.org/10.1101/2021.07.23.453592; this version posted July 24, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract An emerging element in psychiatry is the gut-brain-axis, the bi-direCtional CommuniCation pathways between the gut miCrobiome and the brain. A prominent hypothesis, mostly based on preCliniCal studies, is that individual differences in the gut miCrobiome Composition and drug- induced dysbiosis may be associated with vulnerability to psychiatriC disorders including substance use disorder.
    [Show full text]
  • High-Throughput Sequencing and Unsupervised Analysis Of
    fmicb-11-02066 August 25, 2020 Time: 17:40 # 1 METHODS published: 27 August 2020 doi: 10.3389/fmicb.2020.02066 High-Throughput Sequencing and Unsupervised Analysis of Formyltetrahydrofolate Synthetase (FTHFS) Gene Amplicons to Estimate Acetogenic Community Structure Edited by: Denis Grouzdev, Abhijeet Singh1*, Johan A. A. Nylander2,3, Anna Schnürer1*, Erik Bongcam-Rudloff4 and Federal Centre Research Bettina Müller1 “Fundamentals of Biotechnology” (RAS), Russia 1 Anaerobic Microbiology and Biotechnology Group, Department of Molecular Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden, 2 Department of Bioinformatics and Genetics, Swedish Museum of Natural History, Stockholm, Reviewed by: Sweden, 3 National Bioinformatics Infrastructure Sweden, SciLifeLab, Uppsala, Sweden, 4 SLU-Global Bioinformatics Centre, Ye Deng, Department of Animal Breeding and Genetics, Swedish University of Agricultural Sciences, Uppsala, Sweden Research Center for Eco-environmental Sciences (CAS), China The formyltetrahydrofolate synthetase (FTHFS) gene is a molecular marker of choice to Irena Maus, Bielefeld University, Germany study the diversity of acetogenic communities. However, current analyses are limited *Correspondence: due to lack of a high-throughput sequencing approach for FTHFS gene amplicons and Abhijeet Singh a dedicated bioinformatics pipeline for data analysis, including taxonomic annotation [email protected]; and visualization of the sequence data. In the present study, we combined the [email protected] Anna Schnürer
    [Show full text]
  • Impact of Intestinal Microbiota on Growth and Feed Efficiency
    microorganisms Review Impact of Intestinal Microbiota on Growth and Feed Efficiency in Pigs: A Review Gillian E. Gardiner 1,* , Barbara U. Metzler-Zebeli 2 and Peadar G. Lawlor 3 1 Department of Science, Waterford Institute of Technology, X91 K0EK Co. Waterford, Ireland 2 Unit Nutritional Physiology, Institute of Physiology, Pathophysiology and Biophysics, Department of Biomedical Sciences, University of Veterinary Medicine Vienna, 1210 Vienna, Austria; [email protected] 3 Teagasc, Pig Development Department, Animal and Grassland Research and Innovation Centre, Moorepark, Fermoy, P61 C996 Co. Cork, Ireland; [email protected] * Correspondence: [email protected]; Tel.: +353-51-302-626 Received: 2 October 2020; Accepted: 25 November 2020; Published: 28 November 2020 Abstract: This review summarises the evidence for a link between the porcine intestinal microbiota and growth and feed efficiency (FE), and suggests microbiota-targeted strategies to improve productivity. However, there are challenges in identifying reliable microbial predictors of host phenotype; environmental factors impact the microbe–host interplay, sequential differences along the intestine result in segment-specific FE- and growth-associated taxa/functionality, and it is often difficult to distinguish cause and effect. However, bacterial taxa involved in nutrient processing and energy harvest, and those with anti-inflammatory effects, are consistently linked with improved productivity. In particular, evidence is emerging for an association of Treponema and methanogens such as Methanobrevibacter in the small and large intestines and Lactobacillus in the large intestine with a leaner phenotype and/or improved FE. Bacterial carbohydrate and/or lipid metabolism pathways are also generally enriched in the large intestine of leaner pigs and/or those with better growth/FE.
    [Show full text]
  • Comparison of Rumen Microbe Taxa Among Wild and Domestic Ruminants
    COMPARISON OF RUMEN MICROBE TAXA AMONG WILD AND DOMESTIC RUMINANTS A thesis presented to the Faculty of the Graduate School University of Missouri In partial fulfillment of the requirements for the Degree PhD By TASIA MARIE TAXIS Dr. William R. Lamberson Thesis Advisor DECEMBER 2015 The undersigned, appointed by the Dean of the Graduate School, have examined the thesis entitled COMPARISON OF RUMEN MICROBE TAXA AMONG WILD AND DOMESTIC RUMINANTS Presented by Tasia Marie Taxis A candidate for the degree of PhD And hereby certify that in their opinion it is worthy of acceptance. Dr. William R. Lamberson, advisor University of Missouri, Columbia, MO Dr. Robert L. Kallenbach, external committee member University of Missouri, Columbia, MO Dr. Gavin C. Conant University of Missouri, Columbia, MO Dr. Kristi M. Cammack University of Wyoming, Laramie, WY DEDICATION My professional and personal growth would have been stunted if it weren’t for the guidance and support of so many people, too many to mention. I would like to acknowledge my biological, academic, and adopted-Mizzou family. My biological family provided my foundation on which I still stand. While physically 1,000 miles away, they were always close. My mother, Mary Ann Taxis, has always grounded me back to the ‘go get it’ girl she raised. My father, Craig Taxis, has always sent extra hugs and love, which in a note or voice, could always be felt. My brother, Travis Taxis, was honest and provided the kick when I needed it and support when I didn’t. He will forever be my best friend and favorite hunting partner.
    [Show full text]
  • Faecal Microbiota in Patients with Neurogenic Bowel Dysfunction and Spinal Cord Injury Or Multiple Sclerosis—A Systematic Review
    Journal of Clinical Medicine Review Faecal Microbiota in Patients with Neurogenic Bowel Dysfunction and Spinal Cord Injury or Multiple Sclerosis—A Systematic Review Willemijn Faber 1,*, Janneke Stolwijk-Swuste 2 , Florian van Ginkel 3 , Janneke Nachtegaal 4, Erwin Zoetendal 5, Renate Winkels 6 and Ben Witteman 6 1 Heliomare Rehabilitation Centre, 1949 EC Wijk aan Zee, The Netherlands 2 Center of Excellence for Rehabilitation Medicine, Brain Center Rudolf Magnus, University Medical Center Utrecht and De Hoogstraat Rehabilitation, Utrecht University, 3583 TM Utrecht, The Netherlands; [email protected] 3 Faculty of Medicine, Utrecht University, 3584 CG Utrecht, The Netherlands; [email protected] 4 Heliomare Rehabilitation Center, Department of Research & Development, 1949 EC Wijk aan Zee, The Netherlands; [email protected] 5 Laboratory of Microbiology, Wageningen University and Research, Wageningen University, 6708 PB Wageningen, The Netherlands; [email protected] 6 Division of Human Nutrition and health, Wageningen University and Research, Wageningen University, 6708 PB Wageningen, The Netherlands; [email protected] (R.W.); [email protected] (B.W.) * Correspondence: [email protected]; Tel.: +31-88-9208257 Abstract: Background: Neurogenic bowel dysfunction (NBD) frequently occurs in patients with spinal cord injury (SCI) and multiple sclerosis (MS) with comparable symptoms and is often difficult Citation: Faber, W.; Stolwijk-Swuste, to treat. It has been suggested the gut microbiota might influence the course of NBD. We system- J.; van Ginkel, F.; Nachtegaal, J.; atically reviewed the literature on the composition of the gut microbiota in SCI and MS, and the Zoetendal, E.; Winkels, R.; Witteman, possible role of neurogenic bowel function, diet and antibiotic use.
    [Show full text]
  • Expansion of and Reclassification Within the Family Lachnospiraceae
    University of Massachusetts Amherst ScholarWorks@UMass Amherst Doctoral Dissertations Dissertations and Theses November 2016 Expansion of and reclassification within the family Lachnospiraceae Kelly N. Haas University of Massachusetts Amherst Follow this and additional works at: https://scholarworks.umass.edu/dissertations_2 Part of the Biodiversity Commons, Bioinformatics Commons, Environmental Microbiology and Microbial Ecology Commons, Evolution Commons, Genomics Commons, Microbial Physiology Commons, Organismal Biological Physiology Commons, Other Ecology and Evolutionary Biology Commons, Other Microbiology Commons, and the Systems Biology Commons Recommended Citation Haas, Kelly N., "Expansion of and reclassification within the family Lachnospiraceae" (2016). Doctoral Dissertations. 843. https://doi.org/10.7275/9055799.0 https://scholarworks.umass.edu/dissertations_2/843 This Open Access Dissertation is brought to you for free and open access by the Dissertations and Theses at ScholarWorks@UMass Amherst. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of ScholarWorks@UMass Amherst. For more information, please contact [email protected]. EXPANSION OF AND RECLASSIFICATION WITHIN THE FAMILY LACHNOSPIRACEAE A dissertation presented by KELLY NICOLE HAAS Submitted to the Graduate School of the University of Massachusetts Amherst in partial fulfilment of the requirements for the degree of DOCTOR OF PHILOSOPHY September 2016 Microbiology Department © Copyright by Kelly Nicole Haas 2016
    [Show full text]
  • Diet and Exercise Orthogonally Alter the Gut Microbiome and Reveal Independent Associations with Anxiety and Cognition
    Kang et al. Molecular Neurodegeneration 2014, 9:36 http://www.molecularneurodegeneration.com/content/9/1/36 RESEARCH ARTICLE Open Access Diet and exercise orthogonally alter the gut microbiome and reveal independent associations with anxiety and cognition Silvia S Kang1, Patricio R Jeraldo2, Aishe Kurti1, Margret E Berg Miller3,4, Marc D Cook3,4, Keith Whitlock3,4, Nigel Goldenfeld5,6, Jeffrey A Woods3,4, Bryan A White5, Nicholas Chia2* and John D Fryer1,7,8* Abstract Background: The ingestion of a high-fat diet (HFD) and the resulting obese state can exert a multitude of stressors on the individual including anxiety and cognitive dysfunction. Though many studies have shown that exercise can alleviate the negative consequences of a HFD using metabolic readouts such as insulin and glucose, a paucity of well-controlled rodent studies have been published on HFD and exercise interactions with regard to behavioral outcomes. This is a critical issue since some individuals assume that HFD-induced behavioral problems such as anxiety and cognitive dysfunction can simply be exercised away. To investigate this, we analyzed mice fed a normal diet (ND), ND with exercise, HFD diet, or HFD with exercise. Results: We found that mice on a HFD had robust anxiety phenotypes but this was not rescued by exercise. Conversely, exercise increased cognitive abilities but this was not impacted by the HFD. Given the importance of the gut microbiome in shaping the host state, we used 16S rRNA hypervariable tag sequencing to profile our cohorts and found that HFD massively reshaped the gut microbial community in agreement with numerous published studies.
    [Show full text]
  • The Dynamic Changes of Gut Microbiota in Muc2 Deficient Mice
    International Journal of Molecular Sciences Article The Dynamic Changes of Gut Microbiota in Muc2 Deficient Mice Minna Wu 1, Yaqi Wu 1, Jianmin Li 1, Yonghua Bao 2, Yongchen Guo 2 and Wancai Yang 1,2,3,* 1 College of Basic Medicine, Xinxiang Medical University, Xinxiang 453003, Henan, China; [email protected] (M.W.); [email protected] (Y.W.); [email protected] (J.L.) 2 Department of Pathology, Institute of Precision Medicine, Jining Medical University, Jining 272067, Shandong, China; [email protected] (Y.B.); [email protected] (Y.G.) 3 Department of Pathology, University of Illinois at Chicago, Chicago, IL 60612, USA * Correspondence: [email protected]; Tel.: +86-537-363-6566 Received: 8 August 2018; Accepted: 12 September 2018; Published: 18 September 2018 Abstract: Gut dysbiosis is associated with colitis-associated colorectal carcinogenesis, and the genetic deficiency of the Muc2 gene causes spontaneous development of colitis and colorectal cancer. Whether there are changes of gut microbiota and a linkage between the changes of microbiota and intestinal pathology in Muc2−/− mice are unclear. Muc2−/− and Muc2+/+ mice were generated by backcrossing from Muc2+/− mice, and the fecal samples were collected at different dates (48th, 98th, 118th, 138th, and 178th day). Gut microbiota were analyzed by high-throughput sequencing with the universal 16S rRNA primers (V3–V5 region). All mice were sacrificed at day 178 to collect colonic tissue and epithelial cells for the analysis of histopathology and inflammatory cytokines. On the 178th day, Muc2−/− mice developed colorectal chronic colitis, hyperplasia, adenomas and adenocarcinomas, and inflammatory cytokines (e.g., cyclooxygenase 2 (COX-2), interleukin 6 (IL-6), tumor necrosis factor-α (TNF-α), interleukin 1 β (IL-1β), i-kappa-B-kinase β (IKKβ)) were significantly increased in colonic epithelial cells of Muc2−/− mice.
    [Show full text]